Scale
Reconsidering the benefits of scaling, at scale, and within scalar boundaries, is always a good measure to ensure societal health pathways can exist with the entire market, some of the market, markets, and market(s), and none of a market(s).
Reconsidering the benefits of scaling, at scale, and within scalar boundaries, is always a good measure to ensure societal health pathways can exist with the entire market, some of the market, markets, and market(s), and none of a market(s).